COMPARISON OF THE MUTAGENICITY AND TERATOGENICITY OF CYCLOPHOSPHAMIDE AND ITS ACTIVE METABOLITES, 4-HYDROXYCYCLOPHOSPHAMIDE, PHOSPHORAMIDE MUSTARD, AND ACROLEIN

被引：0

|

作者：

HALES, BF

机构：

来源：

CANCER RESEARCH | 1982年 / 42卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3016 / 3021

页数：6

相关论文

共 21 条

[1] PHOSPHATE CATALYZED CONVERSION OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE TO PHOSPHORAMIDE MUSTARD AND ACROLEIN
SLADEK, NE
BORCH, RF
LOW, JE
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 214 - 214
[2] CONVERSION OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE TO PHOSPHORAMIDE MUSTARD AND ACROLEIN MEDIATED BY BIFUNCTIONAL CATALYSTS
LOW, JE
BORCH, RF
SLADEK, NE
CANCER RESEARCH, 1982, 42 (03) : 830 - 837
[3] TERATOGENICITY OF CYCLOPHOSPHAMIDE METABOLITES - PHOSPHORAMIDE MUSTARD, ACROLEIN, AND 4-KETOCYCLOPHOSPHAMIDE IN RAT EMBRYOS CULTURED INVITRO
MIRKES, PE
FANTEL, AG
GREENAWAY, JC
SHEPARD, TH
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1981, 58 (02) : 322 - 330
[4] Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with thiotepa and carboplatin
de Jonge, ME
Huitema, ADR
van Dam, SM
Rodenhuis, S
Beijnen, JH
THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 756 - 765
[5] CYCLOPHOSPHAMIDE METABOLISM .12. CYTO-TOXIC ACTIVITY RELATIVE TO 4-HYDROXYCYCLOPHOSPHAMIDE AND PHOSPHORAMIDE MUSTARD CONCENTRATIONS IN THE PLASMA OF CYCLOPHOSPHAMIDE-TREATED RATS
POWERS, JF
SLADEK, NE
CANCER RESEARCH, 1983, 43 (03) : 1101 - 1106
[6] PHARMACOKINETICS OF CYCLOPHOSPHAMIDE AND CYCLOPHOSPHAMIDE METABOLITES IN THE MOUSE AND THEIR INFLUENCE ON THE THERAPEUTIC EFFECT OF ACTIVATED CYCLOPHOSPHAMIDE (4-HYDROXYCYCLOPHOSPHAMIDE)
VOELCKER, G
HAEGLSPERGER, R
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1982, 32-1 (06): : 639 - 647
[7] Cyclophosphamide metabolites 4-hydroxycyclophosphamide and acrolein exert strenuous cardiotoxicity in AC16 human cardiomyocytes, at clinical relevant concentrations
Dionisio, F.
Duarte-Araujo, M.
Bastos, M. D. L.
Carvalho, F. D.
Costa, V. M.
TOXICOLOGY LETTERS, 2019, 314 : S168 - S168
[8] A COMPARISON OF SISTER-CHROMATID EXCHANGE IN MOUSE PERIPHERAL-BLOOD LYMPHOCYTES EXPOSED INVITRO AND INVIVO TO PHOSPHORAMIDE MUSTARD AND 4-HYDROXYCYCLOPHOSPHAMIDE
BRYANT, MF
EREXSON, GL
KLIGERMAN, AD
MUTATION RESEARCH, 1989, 222 (03): : 271 - 277
[9] PLASMA-CONCENTRATIONS OF 4-HYDROXYCYCLOPHOSPHAMIDE AND PHOSPHORAMIDE MUSTARD IN PATIENTS REPEATEDLY GIVEN HIGH-DOSES OF CYCLOPHOSPHAMIDE IN PREPARATION FOR BONE-MARROW TRANSPLANTATION
SLADEK, NE
DOEDEN, D
POWERS, JF
KRIVIT, W
CANCER TREATMENT REPORTS, 1984, 68 (10): : 1247 - 1254
[10] THE INTERACTION OF GLUTATHIONE WITH 4-HYDROXYCYCLOPHOSPHAMIDE AND PHOSPHORAMIDE MUSTARD, STUDIED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
DIRVEN, HAAM
VENEKAMP, JC
VANOMMEN, B
VANBLADEREN, PJ
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 93 (03) : 185 - 196